GENEVA, Sept. 16 -- CRISPR THERAPEUTICS AG (Baarerstrasse 146300 Zug) filed a patent application (PCT/IB2025/052358) for "MODULATING EXPRESSION OF AGT (ANGIOTENSINOGEN) GENE" on Mar 04, 2025. With publication no. WO/2025/186726, the details related to the patent application was published on Sep 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): DEQUEANT, Mary-Lee (105 West First StreetSouth Boston, Massachusetts 02127), KYRYCHENKO, Viktoriia (105 West First StreetSouth Boston, MA 02127), D'SOUZA, Sanjay (105 West First StreetSouth Boston, MA 02127)
Abstract:
The present disclosure relate...